Boursorama Sa:企業の戦略・SWOT・財務分析

◆英語タイトル:Boursorama Sa - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3471
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Boursorama Sa – Strategy, SWOT and Corporate Finance Report
Summary

Boursorama Sa – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Boursorama SA (Boursorama), a subsidiary of Societe Generale SA, is a provider of online financial solutions in the areas of banking, financial information, and brokerage. It provides a range of banking solutions such as transactional and investment accounts; debit and credit cards;lending for personal needs, mortgage, property, and other financing requirements; and investment products such as Undertakings for Collective Investment in Transferable Securities (UCITS) and life insurance vehicles, which includes a range of solutions for investing in equities, trackers, warrants, certificates, turbos, deferred settlement service, CFDs, and forex, among others. It provides users access to stock quotes, financial and economic news, and information about companies. Boursorama is headquartered in Cedex, Paris, France.

Scope

- Detailed information on Boursorama Sa required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Boursorama Sa in the form of a SWOT analysis
- An in-depth view of the business model of Boursorama Sa including a breakdown and examination of key business segments
- Intelligence on Boursorama Sa’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Boursorama Sa, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Boursorama Sa and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Boursorama Sa as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Boursorama Sa’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Boursorama SA: Company Overview
Boursorama SA: Overview and Key Facts
Boursorama SA: Overview
Boursorama SA: Key Facts
Boursorama SA: Key Employees
Boursorama SA: Major Products and Services
Boursorama SA: Company History
Boursorama SA: Management Statement
Boursorama SA: Locations and Subsidiaries
Boursorama SA: Key Competitors
Boursorama SA: Company Analysis
Boursorama SA: Business Description
Boursorama SA: SWOT Analysis
Boursorama SA: SWOT Overview
Boursorama SA: Strengths
Boursorama SA: Weaknesses
Boursorama SA: Opportunities
Boursorama SA: Threats
Boursorama SA: Corporate Financial Deals Activity
Boursorama SA: Financial Deals Overview
Boursorama SA: Top Deals 2015 – 2019YTD*
Boursorama SA: Advisors
Boursorama SA: Top Legal Advisors
Boursorama SA: Divestments
Boursorama SA: Recent Developments
Boursorama SA: News and Events Summary
Boursorama SA: Contracts
Boursorama SA: Financial Deals
Boursorama SA: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Boursorama SA: Key Facts
Table 2: Boursorama SA: Key Employees
Table 3: Boursorama SA: Company History
Table 4: Boursorama SA: Locations and Subsidiaries
Table 5: Boursorama SA: Key Competitors
Table 6: Boursorama SA: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Boursorama SA: Top Deals 2015 - 2019YTD*
Table 8: Boursorama SA: Legal Advisor Ranking by Value (US$m)
Table 9: Boursorama SA: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 10: Boursorama SA: Divestments by Geography (2015 - YTD*2019)
Table 11: Boursorama SA: News and Events Summary
Table 12: Boursorama SA: Contracts
Table 13: Boursorama SA: Financial Deals
Table 14: Boursorama SA: Strategy and Operations

★海外企業調査レポート[Boursorama Sa:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Western Refining, Inc. (WNR)-石油・ガス分野:企業M&A・提携分析
    Summary Western Refining, Inc. (Western Refining) is a downstream oil and gas company that refines crude and markets its derivatives. The company’s product portfolio comprises gasoline, diesel fuel, jet fuel, and asphalt. The company operates refineries in El Paso, Texas; Gallup, Mexico; and St. Pau …
  • Indoco Remedies Ltd (INDOCO):製薬・医療:M&Aディール及び事業提携情報
    Summary Indoco Remedies Ltd (Indoco Remedies) is a research-oriented pharmaceutical company that manufactures and markets formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). It has products portfolio in various therapeutic segments such as cardiovascular, central nervo …
  • Rosneft Oil Co (ROSN):石油・ガス:M&Aディール及び事業提携情報
    Summary Rosneft Oil Company (Rosneft) is a vertically integrated oil and gas company that explores for, develops and produces crude oil, natural gas and condensates; and refines, markets and distributes petroleum products and petrochemicals. It has exploration assets across Western Siberia, Eastern …
  • ProQR Therapeutics NV (PRQR):企業の財務・戦略的SWOT分析
    Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide …
  • Aptuit LLC-製薬・医療分野:企業M&A・提携分析
    Summary Aptuit LLC (Aptuit) is a provider of drug discovery and development services. The company offer wide range of services such as manufacturing, project management, small and large molecules analysis, formulation development, integrated chemistry, API route scouting and process development, con …
  • Parker-Hannifin Corporation:企業の戦略・SWOT・財務分析
    Parker-Hannifin Corporation - Strategy, SWOT and Corporate Finance Report Summary Parker-Hannifin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Oil & Gas Development Co Ltd (OGDC)
    Oil & Gas Development Co Ltd (OGDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • CeoTronics AG (CEK):企業の財務・戦略的SWOT分析
    CeoTronics AG (CEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Caisse de depot et placement du Quebec:企業のM&A・事業提携・投資動向
    Caisse de depot et placement du Quebec - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Caisse de depot et placement du Quebec Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Align Technology, Inc.:戦略・SWOT・企業財務分析
    Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report Summary Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Karachaganak Petroleum Operating BV:企業の戦略的SWOT分析
    Karachaganak Petroleum Operating BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Bioconnect Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Bioconnect Systems, Inc. (Bioconnect) is a medical device company that designs, manufactures and distributes surgical and medical products. The company offers optiflow technology, which is used to provide quick joining vessels. Its technology also provides services such as control over the g …
  • Juvenile Diabetes Research Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type one diabetes. The organization conducts clinical trials for curing, preventing and treating for type one diabetes and its complications; and researching new drugs for patients to man …
  • Systex Corp (6214):企業の財務・戦略的SWOT分析
    Systex Corp (6214) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Power Corporation of Canada:企業の戦略・SWOT・財務情報
    Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report Summary Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bioceros BV-製薬・医療分野:企業M&A・提携分析
    Summary Bioceros BV (Bioceros) is a biopharmaceutical company which provides services related to preclinical development of monoclonal antibodies. The company offers GMP-ready protein producing cell lines. The company provides services which include monoclonal antibody generation, cell line and proc …
  • UCB SA (UCB)-医療機器分野:企業M&A・提携分析
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • LCC International, Inc.:企業の戦略的SWOT分析
    LCC International, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • SYNNEX Corporation:企業の戦略・SWOT・財務情報
    SYNNEX Corporation - Strategy, SWOT and Corporate Finance Report Summary SYNNEX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SAP SE:企業の戦略・SWOT・財務情報
    SAP SE - Strategy, SWOT and Corporate Finance Report Summary SAP SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆